23 results on '"Cherry, Cynthia R."'
Search Results
2. Plasma cell free PD-L1 RNA expression correlated with tissue PD-L1 immunohistochemical staining and tumor mutation burden in non-small cell lung cancer.
3. Association of extended dosing intervals or delays in pembrolizumab-based regimens with survival outcomes in advanced non-small cell lung cancer
4. The real-world incidence of immunotherapy-related thyroid dysfunction: A retrospective analysis of a single center's experience over five years.
5. Demographic stratification of inflammatory signature in lung cancer patients in North Carolina: A prospective cohort study.
6. The use of liquid and tissue biopsy genomic testing in lung cancer: A single-institution experience.
7. Immune pneumonitis-related treatment discontinuations and outcomes in metastatic non-small cell lung cancer treated with nivolumab: A pooled analysis from a multi-institutional international collaboration.
8. Antibiotic use and overall survival in lung cancer patients receiving nivolumab.
9. Outcomes of immunomodulatory radiation strategies in combination with nivolumab compared with single agent nivolumab in lung cancer patients.
10. Evaluating the utility of pretreatment C-reactive protein (CRP) in survival stratification of advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint blockade (ICB): A prospective cohort study.
11. Post- progression treatment patterns in advanced lung cancer patients treated with nivolumab.
12. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database
13. Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
14. Veristrat based stratification of responses to immune checkpoint blockade (ICB).
15. Nonconventional responses and survival benefit of immunotherapy in advanced lung cancer.
16. Efficacy of PD-1 inhibitors in patients with metastatic non-small cell lung cancer (NSCLC) with KRAS or EGFR T790M mutations.
17. Immune related adverse events (irAEs): A unique profile based on tumor type.
18. Sequence of stereotactic ablative radiotherapy and immune checkpoint blockade in the treatment of metastatic lung cancer.
19. Incidence and impact of thromboembolic events in lung cancer patients treated with nivolumab.
20. Outcomes with immune checkpoint inhibitor use in lung cancer patients with hepatic metastases.
21. Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors.
22. Outcomes in patients with stage III non-small cell lung cancer (NSCLC) treated with cisplatin and irinotecan with concurrent thoracic radiotherapy (CRT): A multi-disciplinary thoracic oncology experience at East Carolina University.
23. Co-relation of overall survival with peripheral blood-based inflammatory biomarkers in advanced stage non-small cell lung cancer treated with anti-programmed cell death-1 therapy: results from a single institutional database.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.